
Living therapy: Microbial immunotherapy of Exeliom Biosciences gets a boost
Exeliom Biosciences (Paris, France) is using its unique knowledge of the microbiome-immunomodulation axis to develop next-generation immunotherapies....

Mystery solved: Mysthera Theapeutics launches with $3.5m
Mysthera Therapeutics AG was just founded in Basel, Switzerland by Forty51 Ventures with $3.5m seed capital. Pursuing a first-in-class...

Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlands
Mosa Meat and Meatable welcome the agreement with the Dutch government to conduct pre-approval tastings of cultured meat and seafood in the...

Astraveus SAS bags €16.5m in seed financing
The oversubscribed seed round of Astraveus SAS was led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson Innovation –...

BioSpain breaking records
On its 20th anniversary in Catalonia’s vibrant capital Barcelona, BioSpain 2023 is set to break records in terms of attracting visitors,...

Smarter, faster, cheaper: Veeva shows how
Achieving the highest possible speed in innovation to meet patients’ unmet needs. That was the palpable goal all the pharmaceutical and life sciences...

Seed money for unique topical hair growth inducer
Good news for all those with genetic hormonal hair loss (androgenic alopecia and Alopecia areata): according to the patent specification, an...